Legal & General Group’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,790
Closed -$33.3K 3409
2023
Q1
$33.3K Hold
4,790
﹤0.01% 2939
2022
Q4
$44.2K Hold
4,790
﹤0.01% 2968
2022
Q3
$59K Sell
4,790
-8,065
-63% -$119K ﹤0.01% 2940
2022
Q2
$169K Buy
12,855
+516
+4% +$12.9K ﹤0.01% 2686
2022
Q1
$492K Buy
12,339
+2,652
+27% +$112K ﹤0.01% 2402
2021
Q4
$525K Buy
9,687
+443
+5% +$29.8K ﹤0.01% 2399
2021
Q3
$640K Hold
9,244
﹤0.01% 2352
2021
Q2
$838K Sell
9,244
-1
-0% -$87 ﹤0.01% 2239
2021
Q1
$860K Buy
9,245
+2,532
+38% +$283K ﹤0.01% 2221
2020
Q4
$559K Buy
6,713
+806
+14% +$58.7K ﹤0.01% 2235
2020
Q3
$274K Hold
5,907
﹤0.01% 2308
2020
Q2
$728K Sell
5,907
-10,399
-64% -$1.18M ﹤0.01% 2076
2020
Q1
$1.73M Buy
16,306
+2,253
+16% +$402K ﹤0.01% 1649
2019
Q4
$3.63M Buy
14,053
+909
+7% +$339K ﹤0.01% 1536
2019
Q3
$6.93M Buy
13,144
+375
+3% +$278K ﹤0.01% 1137
2019
Q2
$12M Buy
12,769
+520
+4% +$522K 0.01% 920
2019
Q1
$13.3M Buy
12,249
+7,471
+156% +$6.68M 0.01% 829
2018
Q4
$2.85M Buy
+4,778
New +$3.52M ﹤0.01% 1398

Other funds holding ACB

Legal & General Group's ACB Position: Q2 2023 in Review

Legal & General Group sold out of Aurora Cannabis (ACB) in Q2 2023, closing a stake of 4,790 shares — an estimated $33.3K sold.

Legal & General Group first reported a position in ACB in Q4 2018 and held it in 18 quarters. The position peaked at $13.3M in Q1 2019. 195 funds tracked by Wall St. Rank hold ACB as of Q2 2023.

  • Legal & General Group reported no remaining Aurora Cannabis position as of Q2 2023 after selling out during the quarter.
  • Legal & General Group sold 4,790 Aurora Cannabis shares in Q2 2023, an estimated $33.3K.
  • Legal & General Group first reported a position in Aurora Cannabis in Q4 2018 and held it in 18 quarters.
  • Legal & General Group's Aurora Cannabis position peaked at $13.3M in Q1 2019.
  • 195 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.